A major breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently disabled in various types of tumors, resulting https://socialdosa.com/story12020764/nanobodies-revive-tumor-suppressor-p53-new-new-hope-for-tumor-treatment